nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—GSTT1—chronic obstructive pulmonary disease	0.201	0.302	CbGaD
Cisplatin—GSTM1—chronic obstructive pulmonary disease	0.172	0.258	CbGaD
Cisplatin—GSTP1—chronic obstructive pulmonary disease	0.159	0.239	CbGaD
Cisplatin—MPO—chronic obstructive pulmonary disease	0.134	0.201	CbGaD
Cisplatin—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0133	0.278	CbGbCtD
Cisplatin—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0133	0.278	CbGbCtD
Cisplatin—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0101	0.211	CbGbCtD
Cisplatin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00575	0.12	CbGbCtD
Cisplatin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00543	0.113	CbGbCtD
Cisplatin—BCHE—diaphragm—chronic obstructive pulmonary disease	0.00441	0.0739	CbGeAlD
Cisplatin—MT1A—connective tissue—chronic obstructive pulmonary disease	0.00195	0.0326	CbGeAlD
Cisplatin—MT2A—respiratory system—chronic obstructive pulmonary disease	0.00184	0.0309	CbGeAlD
Cisplatin—GSTT1—respiratory system—chronic obstructive pulmonary disease	0.0018	0.0302	CbGeAlD
Cisplatin—MT2A—connective tissue—chronic obstructive pulmonary disease	0.00162	0.0272	CbGeAlD
Cisplatin—PTGS2—leg—chronic obstructive pulmonary disease	0.00156	0.0262	CbGeAlD
Cisplatin—SLC31A2—bronchus—chronic obstructive pulmonary disease	0.00149	0.025	CbGeAlD
Cisplatin—ATP7B—trachea—chronic obstructive pulmonary disease	0.00146	0.0245	CbGeAlD
Cisplatin—ATP7A—connective tissue—chronic obstructive pulmonary disease	0.0014	0.0235	CbGeAlD
Cisplatin—SLC31A1—respiratory system—chronic obstructive pulmonary disease	0.00136	0.0228	CbGeAlD
Cisplatin—SLC31A2—trachea—chronic obstructive pulmonary disease	0.00134	0.0224	CbGeAlD
Cisplatin—GSTM1—respiratory system—chronic obstructive pulmonary disease	0.00133	0.0223	CbGeAlD
Cisplatin—ATP7A—bronchus—chronic obstructive pulmonary disease	0.00131	0.022	CbGeAlD
Cisplatin—ABCC6—connective tissue—chronic obstructive pulmonary disease	0.00129	0.0216	CbGeAlD
Cisplatin—ATP7A—trachea—chronic obstructive pulmonary disease	0.00118	0.0198	CbGeAlD
Cisplatin—MT1A—lung—chronic obstructive pulmonary disease	0.00117	0.0197	CbGeAlD
Cisplatin—GSTM1—connective tissue—chronic obstructive pulmonary disease	0.00117	0.0196	CbGeAlD
Cisplatin—SOD1—bronchus—chronic obstructive pulmonary disease	0.00115	0.0193	CbGeAlD
Cisplatin—SOD1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00112	0.0188	CbGeAlD
Cisplatin—SLC31A1—bronchus—chronic obstructive pulmonary disease	0.00112	0.0188	CbGeAlD
Cisplatin—ATP7B—lung—chronic obstructive pulmonary disease	0.00105	0.0176	CbGeAlD
Cisplatin—SOD1—trachea—chronic obstructive pulmonary disease	0.00103	0.0173	CbGeAlD
Cisplatin—SLC31A1—trachea—chronic obstructive pulmonary disease	0.00101	0.0169	CbGeAlD
Cisplatin—MT2A—lung—chronic obstructive pulmonary disease	0.000978	0.0164	CbGeAlD
Cisplatin—SLC31A2—lung—chronic obstructive pulmonary disease	0.000961	0.0161	CbGeAlD
Cisplatin—GSTT1—lung—chronic obstructive pulmonary disease	0.000957	0.016	CbGeAlD
Cisplatin—NQO1—respiratory system—chronic obstructive pulmonary disease	0.000931	0.0156	CbGeAlD
Cisplatin—MPO—respiratory system—chronic obstructive pulmonary disease	0.000856	0.0143	CbGeAlD
Cisplatin—ATP7A—lung—chronic obstructive pulmonary disease	0.000847	0.0142	CbGeAlD
Cisplatin—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.000835	0.014	CbGeAlD
Cisplatin—GSTP1—respiratory system—chronic obstructive pulmonary disease	0.000832	0.0139	CbGeAlD
Cisplatin—NQO1—connective tissue—chronic obstructive pulmonary disease	0.000819	0.0137	CbGeAlD
Cisplatin—ABCC5—bronchus—chronic obstructive pulmonary disease	0.000819	0.0137	CbGeAlD
Cisplatin—ABCC6—lung—chronic obstructive pulmonary disease	0.000777	0.013	CbGeAlD
Cisplatin—NQO1—bronchus—chronic obstructive pulmonary disease	0.000766	0.0128	CbGeAlD
Cisplatin—MPO—connective tissue—chronic obstructive pulmonary disease	0.000753	0.0126	CbGeAlD
Cisplatin—NQO1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00075	0.0126	CbGeAlD
Cisplatin—SOD1—lung—chronic obstructive pulmonary disease	0.000741	0.0124	CbGeAlD
Cisplatin—GSTP1—connective tissue—chronic obstructive pulmonary disease	0.000732	0.0123	CbGeAlD
Cisplatin—SLC31A1—lung—chronic obstructive pulmonary disease	0.000722	0.0121	CbGeAlD
Cisplatin—GSTM1—lung—chronic obstructive pulmonary disease	0.000705	0.0118	CbGeAlD
Cisplatin—NQO1—trachea—chronic obstructive pulmonary disease	0.000688	0.0115	CbGeAlD
Cisplatin—GSTP1—bronchus—chronic obstructive pulmonary disease	0.000685	0.0115	CbGeAlD
Cisplatin—GSTP1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00067	0.0112	CbGeAlD
Cisplatin—GSTP1—trachea—chronic obstructive pulmonary disease	0.000615	0.0103	CbGeAlD
Cisplatin—ABCC5—lung—chronic obstructive pulmonary disease	0.000528	0.00885	CbGeAlD
Cisplatin—BCHE—respiratory system—chronic obstructive pulmonary disease	0.000504	0.00844	CbGeAlD
Cisplatin—NQO1—lung—chronic obstructive pulmonary disease	0.000494	0.00828	CbGeAlD
Cisplatin—MPO—lung—chronic obstructive pulmonary disease	0.000454	0.00762	CbGeAlD
Cisplatin—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000449	0.00753	CbGeAlD
Cisplatin—ABCC3—lung—chronic obstructive pulmonary disease	0.000444	0.00743	CbGeAlD
Cisplatin—GSTP1—lung—chronic obstructive pulmonary disease	0.000442	0.0074	CbGeAlD
Cisplatin—BCHE—bronchus—chronic obstructive pulmonary disease	0.000415	0.00695	CbGeAlD
Cisplatin—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.000406	0.0068	CbGeAlD
Cisplatin—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000388	0.0065	CbGeAlD
Cisplatin—BCHE—trachea—chronic obstructive pulmonary disease	0.000372	0.00624	CbGeAlD
Cisplatin—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.00037	0.00619	CbGeAlD
Cisplatin—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000342	0.00573	CbGeAlD
Cisplatin—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000319	0.00535	CbGeAlD
Cisplatin—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000312	0.00524	CbGeAlD
Cisplatin—PTGS2—trachea—chronic obstructive pulmonary disease	0.000287	0.00481	CbGeAlD
Cisplatin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00027	0.0025	CcSEcCtD
Cisplatin—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00249	CcSEcCtD
Cisplatin—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000268	0.00248	CcSEcCtD
Cisplatin—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.00248	CcSEcCtD
Cisplatin—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00248	CcSEcCtD
Cisplatin—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000268	0.00248	CcSEcCtD
Cisplatin—BCHE—lung—chronic obstructive pulmonary disease	0.000267	0.00448	CbGeAlD
Cisplatin—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00248	CcSEcCtD
Cisplatin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00246	CcSEcCtD
Cisplatin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00245	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000263	0.00244	CcSEcCtD
Cisplatin—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00244	CcSEcCtD
Cisplatin—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00243	CcSEcCtD
Cisplatin—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00242	CcSEcCtD
Cisplatin—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00242	CcSEcCtD
Cisplatin—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00241	CcSEcCtD
Cisplatin—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00241	CcSEcCtD
Cisplatin—ABCG2—lung—chronic obstructive pulmonary disease	0.000258	0.00433	CbGeAlD
Cisplatin—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00239	CcSEcCtD
Cisplatin—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00239	CcSEcCtD
Cisplatin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000257	0.00238	CcSEcCtD
Cisplatin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.00238	CcSEcCtD
Cisplatin—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000256	0.00237	CcSEcCtD
Cisplatin—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00236	CcSEcCtD
Cisplatin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000255	0.00236	CcSEcCtD
Cisplatin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000255	0.00236	CcSEcCtD
Cisplatin—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00236	CcSEcCtD
Cisplatin—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00236	CcSEcCtD
Cisplatin—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00234	CcSEcCtD
Cisplatin—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00234	CcSEcCtD
Cisplatin—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00234	CcSEcCtD
Cisplatin—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000252	0.00233	CcSEcCtD
Cisplatin—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00233	CcSEcCtD
Cisplatin—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00233	CcSEcCtD
Cisplatin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00231	CcSEcCtD
Cisplatin—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.00231	CcSEcCtD
Cisplatin—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.0023	CcSEcCtD
Cisplatin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00229	CcSEcCtD
Cisplatin—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00228	CcSEcCtD
Cisplatin—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00228	CcSEcCtD
Cisplatin—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00226	CcSEcCtD
Cisplatin—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00224	CcSEcCtD
Cisplatin—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00224	CcSEcCtD
Cisplatin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00024	0.00222	CcSEcCtD
Cisplatin—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00024	0.00402	CbGeAlD
Cisplatin—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00222	CcSEcCtD
Cisplatin—CYP2B6—lung—chronic obstructive pulmonary disease	0.000238	0.004	CbGeAlD
Cisplatin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.0022	CcSEcCtD
Cisplatin—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00219	CcSEcCtD
Cisplatin—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00218	CcSEcCtD
Cisplatin—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00218	CcSEcCtD
Cisplatin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000234	0.00217	CcSEcCtD
Cisplatin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00217	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00216	CcSEcCtD
Cisplatin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00216	CcSEcCtD
Cisplatin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00216	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000232	0.00215	CcSEcCtD
Cisplatin—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00214	CcSEcCtD
Cisplatin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00211	CcSEcCtD
Cisplatin—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00211	CcSEcCtD
Cisplatin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000227	0.0021	CcSEcCtD
Cisplatin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.0021	CcSEcCtD
Cisplatin—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000226	0.0021	CcSEcCtD
Cisplatin—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00206	CcSEcCtD
Cisplatin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00204	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00022	0.00203	CcSEcCtD
Cisplatin—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000216	0.002	CcSEcCtD
Cisplatin—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00199	CcSEcCtD
Cisplatin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00198	CcSEcCtD
Cisplatin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00198	CcSEcCtD
Cisplatin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00198	CcSEcCtD
Cisplatin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00198	CcSEcCtD
Cisplatin—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00198	CcSEcCtD
Cisplatin—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00198	CcSEcCtD
Cisplatin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000213	0.00197	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00197	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00197	CcSEcCtD
Cisplatin—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00197	CcSEcCtD
Cisplatin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00196	CcSEcCtD
Cisplatin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00196	CcSEcCtD
Cisplatin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00194	CcSEcCtD
Cisplatin—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00194	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00193	CcSEcCtD
Cisplatin—PTGS2—lung—chronic obstructive pulmonary disease	0.000206	0.00345	CbGeAlD
Cisplatin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.0019	CcSEcCtD
Cisplatin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000205	0.0019	CcSEcCtD
Cisplatin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.0019	CcSEcCtD
Cisplatin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000205	0.0019	CcSEcCtD
Cisplatin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00189	CcSEcCtD
Cisplatin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00189	CcSEcCtD
Cisplatin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00187	CcSEcCtD
Cisplatin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00187	CcSEcCtD
Cisplatin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00186	CcSEcCtD
Cisplatin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00186	CcSEcCtD
Cisplatin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00186	CcSEcCtD
Cisplatin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00186	CcSEcCtD
Cisplatin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00186	CcSEcCtD
Cisplatin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00186	CcSEcCtD
Cisplatin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00185	CcSEcCtD
Cisplatin—Infection—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00185	CcSEcCtD
Cisplatin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00185	CcSEcCtD
Cisplatin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00185	CcSEcCtD
Cisplatin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000199	0.00184	CcSEcCtD
Cisplatin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00183	CcSEcCtD
Cisplatin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00182	CcSEcCtD
Cisplatin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00181	CcSEcCtD
Cisplatin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00179	CcSEcCtD
Cisplatin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00179	CcSEcCtD
Cisplatin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00178	CcSEcCtD
Cisplatin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00178	CcSEcCtD
Cisplatin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00178	CcSEcCtD
Cisplatin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.00177	CcSEcCtD
Cisplatin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00176	CcSEcCtD
Cisplatin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00176	CcSEcCtD
Cisplatin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00175	CcSEcCtD
Cisplatin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00174	CcSEcCtD
Cisplatin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00174	CcSEcCtD
Cisplatin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00174	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00173	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00173	CcSEcCtD
Cisplatin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00171	CcSEcCtD
Cisplatin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000184	0.00171	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000183	0.0017	CcSEcCtD
Cisplatin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00169	CcSEcCtD
Cisplatin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00169	CcSEcCtD
Cisplatin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00168	CcSEcCtD
Cisplatin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00168	CcSEcCtD
Cisplatin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00167	CcSEcCtD
Cisplatin—ABCB1—trachea—chronic obstructive pulmonary disease	0.000177	0.00297	CbGeAlD
Cisplatin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00164	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00164	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00164	CcSEcCtD
Cisplatin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00163	CcSEcCtD
Cisplatin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00163	CcSEcCtD
Cisplatin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00162	CcSEcCtD
Cisplatin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00161	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00161	CcSEcCtD
Cisplatin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.0016	CcSEcCtD
Cisplatin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00159	CcSEcCtD
Cisplatin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00159	CcSEcCtD
Cisplatin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000171	0.00159	CcSEcCtD
Cisplatin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00158	CcSEcCtD
Cisplatin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00158	CcSEcCtD
Cisplatin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00017	0.00157	CcSEcCtD
Cisplatin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00017	0.00157	CcSEcCtD
Cisplatin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00157	CcSEcCtD
Cisplatin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00157	CcSEcCtD
Cisplatin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00157	CcSEcCtD
Cisplatin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00156	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00155	CcSEcCtD
Cisplatin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00153	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00152	CcSEcCtD
Cisplatin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.0015	CcSEcCtD
Cisplatin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000162	0.0015	CcSEcCtD
Cisplatin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000162	0.0015	CcSEcCtD
Cisplatin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00016	0.00149	CcSEcCtD
Cisplatin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00016	0.00148	CcSEcCtD
Cisplatin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.00148	CcSEcCtD
Cisplatin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00148	CcSEcCtD
Cisplatin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00148	CcSEcCtD
Cisplatin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00147	CcSEcCtD
Cisplatin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00147	CcSEcCtD
Cisplatin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00145	CcSEcCtD
Cisplatin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00142	CcSEcCtD
Cisplatin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.0014	CcSEcCtD
Cisplatin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000151	0.0014	CcSEcCtD
Cisplatin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.0014	CcSEcCtD
Cisplatin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.0014	CcSEcCtD
Cisplatin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00139	CcSEcCtD
Cisplatin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00137	CcSEcCtD
Cisplatin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00136	CcSEcCtD
Cisplatin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00136	CcSEcCtD
Cisplatin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00134	CcSEcCtD
Cisplatin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00132	CcSEcCtD
Cisplatin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.0013	CcSEcCtD
Cisplatin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00014	0.0013	CcSEcCtD
Cisplatin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00129	CcSEcCtD
Cisplatin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00129	CcSEcCtD
Cisplatin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00129	CcSEcCtD
Cisplatin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00128	CcSEcCtD
Cisplatin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00127	CcSEcCtD
Cisplatin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00126	CcSEcCtD
Cisplatin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00123	CcSEcCtD
Cisplatin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00121	CcSEcCtD
Cisplatin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00121	CcSEcCtD
Cisplatin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.0012	CcSEcCtD
Cisplatin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000129	0.0012	CcSEcCtD
Cisplatin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000129	0.0012	CcSEcCtD
Cisplatin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.0012	CcSEcCtD
Cisplatin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00119	CcSEcCtD
Cisplatin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000128	0.00118	CcSEcCtD
Cisplatin—ABCB1—lung—chronic obstructive pulmonary disease	0.000127	0.00214	CbGeAlD
Cisplatin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00117	CcSEcCtD
Cisplatin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00117	CcSEcCtD
Cisplatin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00117	CcSEcCtD
Cisplatin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00116	CcSEcCtD
Cisplatin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00115	CcSEcCtD
Cisplatin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00115	CcSEcCtD
Cisplatin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00114	CcSEcCtD
Cisplatin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00114	CcSEcCtD
Cisplatin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00113	CcSEcCtD
Cisplatin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00113	CcSEcCtD
Cisplatin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00113	CcSEcCtD
Cisplatin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00113	CcSEcCtD
Cisplatin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00111	CcSEcCtD
Cisplatin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00109	CcSEcCtD
Cisplatin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00107	CcSEcCtD
Cisplatin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00107	CcSEcCtD
Cisplatin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00106	CcSEcCtD
Cisplatin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00103	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00103	CcSEcCtD
Cisplatin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00103	CcSEcCtD
Cisplatin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.001	CcSEcCtD
Cisplatin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000995	CcSEcCtD
Cisplatin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000984	CcSEcCtD
Cisplatin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000977	CcSEcCtD
Cisplatin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000951	CcSEcCtD
Cisplatin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000941	CcSEcCtD
Cisplatin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00093	CcSEcCtD
Cisplatin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.98e-05	0.000924	CcSEcCtD
Cisplatin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000917	CcSEcCtD
Cisplatin—Erythema—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000917	CcSEcCtD
Cisplatin—Pain—Prednisolone—chronic obstructive pulmonary disease	9.5e-05	0.00088	CcSEcCtD
Cisplatin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	9.33e-05	0.000864	CcSEcCtD
Cisplatin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	9.18e-05	0.00085	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	9.16e-05	0.000848	CcSEcCtD
Cisplatin—Anaemia—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000847	CcSEcCtD
Cisplatin—Malaise—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000827	CcSEcCtD
Cisplatin—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.57e-05	0.000794	CcSEcCtD
Cisplatin—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.42e-05	0.00078	CcSEcCtD
Cisplatin—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.39e-05	0.000778	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000775	CcSEcCtD
Cisplatin—Discomfort—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000771	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	8.19e-05	0.000758	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	8.08e-05	0.000748	CcSEcCtD
Cisplatin—Oedema—Prednisone—chronic obstructive pulmonary disease	8.08e-05	0.000748	CcSEcCtD
Cisplatin—Infection—Prednisone—chronic obstructive pulmonary disease	8.02e-05	0.000743	CcSEcCtD
Cisplatin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000734	CcSEcCtD
Cisplatin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.00073	CcSEcCtD
Cisplatin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.000727	CcSEcCtD
Cisplatin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000723	CcSEcCtD
Cisplatin—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000713	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000682	CcSEcCtD
Cisplatin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000672	CcSEcCtD
Cisplatin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.02e-05	0.00065	CcSEcCtD
Cisplatin—Rash—Prednisolone—chronic obstructive pulmonary disease	7.01e-05	0.000649	CcSEcCtD
Cisplatin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7e-05	0.000648	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000616	CcSEcCtD
Cisplatin—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.6e-05	0.000611	CcSEcCtD
Cisplatin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000591	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000551	CcSEcCtD
Cisplatin—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.000537	CcSEcCtD
Cisplatin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.53e-05	0.000512	CcSEcCtD
Cisplatin—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.13e-05	0.000476	CcSEcCtD
Cisplatin—Rash—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000472	CcSEcCtD
Cisplatin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000471	CcSEcCtD
Cisplatin—Nausea—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000444	CcSEcCtD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.34e-05	0.000197	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	2.28e-05	0.000192	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	2.26e-05	0.00019	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.21e-05	0.000186	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.21e-05	0.000186	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	2.19e-05	0.000184	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.18e-05	0.000183	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	2.17e-05	0.000183	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	2.17e-05	0.000183	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.17e-05	0.000182	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.16e-05	0.000182	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.15e-05	0.000181	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.14e-05	0.00018	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	2.14e-05	0.00018	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.14e-05	0.00018	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	2.12e-05	0.000178	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GCLC—chronic obstructive pulmonary disease	2.12e-05	0.000178	CbGpPWpGaD
Cisplatin—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.11e-05	0.000177	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	2.1e-05	0.000177	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.08e-05	0.000175	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HDAC2—chronic obstructive pulmonary disease	2.06e-05	0.000173	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	2.05e-05	0.000173	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.05e-05	0.000173	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.05e-05	0.000173	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.04e-05	0.000171	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.03e-05	0.000171	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	2.01e-05	0.000169	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2e-05	0.000168	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	1.99e-05	0.000167	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.98e-05	0.000167	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	1.98e-05	0.000167	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.97e-05	0.000166	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.97e-05	0.000166	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.96e-05	0.000165	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.96e-05	0.000165	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.96e-05	0.000165	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.94e-05	0.000164	CbGpPWpGaD
Cisplatin—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.94e-05	0.000163	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CTGF—chronic obstructive pulmonary disease	1.93e-05	0.000163	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	1.93e-05	0.000162	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KL—chronic obstructive pulmonary disease	1.92e-05	0.000161	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	1.91e-05	0.000161	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL1B—chronic obstructive pulmonary disease	1.89e-05	0.00016	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	1.89e-05	0.000159	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	1.89e-05	0.000159	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.86e-05	0.000157	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.85e-05	0.000156	CbGpPWpGaD
Cisplatin—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.84e-05	0.000155	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—ALB—chronic obstructive pulmonary disease	1.84e-05	0.000155	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.8e-05	0.000151	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.8e-05	0.000151	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	1.78e-05	0.00015	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.78e-05	0.00015	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.00015	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.78e-05	0.00015	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GCLC—chronic obstructive pulmonary disease	1.76e-05	0.000148	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.76e-05	0.000148	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.76e-05	0.000148	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.75e-05	0.000147	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.74e-05	0.000146	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	1.74e-05	0.000146	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.000144	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	1.7e-05	0.000143	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.67e-05	0.000141	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.65e-05	0.000139	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.64e-05	0.000138	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	1.63e-05	0.000138	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.63e-05	0.000137	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.61e-05	0.000136	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CTGF—chronic obstructive pulmonary disease	1.61e-05	0.000135	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	1.6e-05	0.000135	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	1.6e-05	0.000135	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	1.6e-05	0.000134	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.000132	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.56e-05	0.000131	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	1.56e-05	0.000131	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	1.53e-05	0.000128	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.52e-05	0.000128	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.52e-05	0.000128	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.51e-05	0.000127	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.51e-05	0.000127	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.5e-05	0.000126	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.5e-05	0.000126	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	1.5e-05	0.000126	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	1.49e-05	0.000125	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.49e-05	0.000125	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.48e-05	0.000125	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—chronic obstructive pulmonary disease	1.48e-05	0.000125	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.000125	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.48e-05	0.000125	CbGpPWpGaD
Cisplatin—XDH—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.46e-05	0.000123	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	1.46e-05	0.000123	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EGFR—chronic obstructive pulmonary disease	1.44e-05	0.000122	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000121	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.44e-05	0.000121	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB3—chronic obstructive pulmonary disease	1.44e-05	0.000121	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.42e-05	0.00012	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.4e-05	0.000118	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	1.4e-05	0.000118	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000117	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.37e-05	0.000115	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.36e-05	0.000115	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.35e-05	0.000114	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	1.34e-05	0.000113	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.33e-05	0.000112	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.31e-05	0.00011	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.3e-05	0.00011	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.000109	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.26e-05	0.000106	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000104	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.23e-05	0.000104	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	1.23e-05	0.000104	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.22e-05	0.000102	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	1.22e-05	0.000102	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.21e-05	0.000102	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NOS2—chronic obstructive pulmonary disease	1.2e-05	0.000101	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ALB—chronic obstructive pulmonary disease	1.18e-05	9.96e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	1.18e-05	9.9e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.16e-05	9.74e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	9.62e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.13e-05	9.55e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-05	9.53e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.11e-05	9.36e-05	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL6—chronic obstructive pulmonary disease	1.11e-05	9.34e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.09e-05	9.17e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	9.09e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.07e-05	9.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.07e-05	8.99e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.07e-05	8.97e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.06e-05	8.94e-05	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.05e-05	8.85e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.05e-05	8.83e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.04e-05	8.79e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	8.78e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.04e-05	8.74e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.03e-05	8.71e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.03e-05	8.7e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	8.7e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.03e-05	8.69e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	8.6e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SERPINE1—chronic obstructive pulmonary disease	1.01e-05	8.49e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ALB—chronic obstructive pulmonary disease	1.01e-05	8.47e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.92e-06	8.35e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.84e-06	8.28e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ALB—chronic obstructive pulmonary disease	9.8e-06	8.25e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	9.65e-06	8.12e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.64e-06	8.12e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NOS3—chronic obstructive pulmonary disease	9.63e-06	8.1e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.62e-06	8.1e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.61e-06	8.09e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.6e-06	8.08e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.41e-06	7.93e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.37e-06	7.89e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.32e-06	7.84e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.15e-06	7.7e-05	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.15e-06	7.7e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.14e-06	7.7e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.05e-06	7.62e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.97e-06	7.55e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ALB—chronic obstructive pulmonary disease	8.79e-06	7.4e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.67e-06	7.3e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.58e-06	7.23e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.58e-06	7.23e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ALB—chronic obstructive pulmonary disease	8.43e-06	7.1e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—NOS3—chronic obstructive pulmonary disease	8.41e-06	7.08e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.23e-06	6.93e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—NOS3—chronic obstructive pulmonary disease	8.06e-06	6.79e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.02e-06	6.75e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	7.99e-06	6.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.96e-06	6.7e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.9e-06	6.66e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.88e-06	6.63e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	7.87e-06	6.62e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	7.81e-06	6.58e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.72e-06	6.5e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.65e-06	6.44e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.56e-06	6.37e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KL—chronic obstructive pulmonary disease	7.43e-06	6.25e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.37e-06	6.2e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.36e-06	6.19e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.34e-06	6.18e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ALB—chronic obstructive pulmonary disease	7.31e-06	6.15e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.23e-06	6.09e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.18e-06	6.04e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.16e-06	6.03e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.15e-06	6.02e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.13e-06	6.01e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.06e-06	5.94e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—NOS3—chronic obstructive pulmonary disease	6.99e-06	5.88e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.98e-06	5.88e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.9e-06	5.81e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.65e-06	5.6e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.61e-06	5.57e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.58e-06	5.54e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.48e-06	5.46e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFB1—chronic obstructive pulmonary disease	6.36e-06	5.36e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.36e-06	5.35e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.3e-06	5.31e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—chronic obstructive pulmonary disease	6.24e-06	5.25e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.24e-06	5.25e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	6.21e-06	5.23e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	5.94e-06	5e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.64e-06	4.75e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.58e-06	4.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	5.57e-06	4.69e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.52e-06	4.65e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.44e-06	4.58e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.3e-06	4.46e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.27e-06	4.44e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.23e-06	4.4e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.21e-06	4.39e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.09e-06	4.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.07e-06	4.27e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.94e-06	4.16e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.87e-06	4.1e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.86e-06	4.09e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.81e-06	4.05e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—chronic obstructive pulmonary disease	4.8e-06	4.04e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	4.75e-06	4e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	4.75e-06	4e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.69e-06	3.95e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	4.64e-06	3.91e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.62e-06	3.89e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	4.54e-06	3.82e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.38e-06	3.69e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	4.28e-06	3.61e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.24e-06	3.57e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.1e-06	3.45e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.05e-06	3.41e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.91e-06	3.29e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	3.91e-06	3.29e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.86e-06	3.25e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	3.73e-06	3.14e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.65e-06	3.08e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.6e-06	3.03e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.59e-06	3.03e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.41e-06	2.87e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.36e-06	2.83e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	3.27e-06	2.75e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.18e-06	2.68e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	3.14e-06	2.64e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.13e-06	2.63e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	3e-06	2.53e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	2.47e-06	2.08e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	2.42e-06	2.04e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.32e-06	1.95e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.22e-06	1.87e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.16e-06	1.82e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.07e-06	1.74e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	1.86e-06	1.57e-05	CbGpPWpGaD
